Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Cited by
Items 401–500 of 1,013
Sharma, S., De Carvalho, D. D., Jeong, S., Jones, P. A., & Liang, G. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001286 · Cited by 119
“DNA methylation inhibitors like 5-aza-CdR, widely used to inhibit aberrant methylation in cancer, target DNMTs by trapping them on DNA [55].”
BackgroundSelf-citationHuang, Y., Sun, J., Zhang, L., Li, C., Womack, J. E., Li, Z., Lan, X., Lei, C., Zhang, C., Zhao, X., et al. (2014) · Scientific Reports · doi:10.1038/srep06546 · Cited by 129
Epigenetic regulation of immune escape genes in cancer
Tomasi, T. B., Magner, W. J., & Khan, A. N. H. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0164-4 · Cited by 146
DNA methylation in mammalian development and disease
Dean, W., Lucifero, D., & Santos, F. (2005) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20037 · Cited by 113
Genome-wide tracking of unmethylated DNA Alu repeats in normal and cancer cells
Rodriguez, J., Vives, L., Jordà, M., Morales, C., Muñoz, M., Vendrell, E., & Peinado, M. A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1105 · Cited by 112
Vlaanderen, J., Moore, L. E., Smith, M. T., Lan, Q., Zhang, L., Skibola, C. F., Rothman, N., & Vermeulen, R. (2010) · Occupational and Environmental Medicine · doi:10.1136/oem.2008.042788 · Cited by 112
Floris, I., Descamps, B., Vardeu, A., Mitić, T., Posadino, A. M., Shantikumar, S., Sala‐Newby, G. B., Capobianco, G., Mangialardi, G., Howard, L., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304730 · Cited by 119
The next innovation cycle in toxicogenomics: Environmental epigenetics
Reamon-Buettner, S. M., MUTSCHLER, V., & Borlak, J. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.01.003 · Cited by 129
Koturbash, I., Pogribny, I. P., & Kovalchuk, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.084 · Cited by 129
PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.
Vanaja, D. K., Ballman, K. V., Morlan, B. W., Cheville, J. C., Neumann, R. M., Lieber, M. M., Tindall, D. J., & Young, C. Y. F. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2072 · Cited by 118
Methyl Deficiency, Alterations in Global Histone Modifications, and Carcinogenesis
Pogribny, I. P., Tryndyak, V., Muskhelishvili, L., Rusyn, I., & Ross, S. A. (2007) · Journal of Nutrition · doi:10.1093/jn/137.1.216s · Cited by 132
Mechanistic Insights on the Inhibition of C5 DNA Methyltransferases by Zebularine
Champion, C., Guianvarc’h, D., Sénamaud‐Beaufort, C., Jurkowska, R. Z., Jeltsch, A., Ponger, L., Arimondo, P. B., & Guieysse‐Peugeot, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012388 · Cited by 118
Epigenetic mechanisms in developmental programming of adult disease
Chen, M., & Zhang, L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.008 · Cited by 126
Ly, A., Hoyt, L., Crowell, J., & Kim, Y. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4554 · Cited by 133
Epigenetic mechanisms of memory formation and reconsolidation
Jarome, T. J., & Lubin, F. D. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.08.002 · Cited by 110
Animal Models to Study Environmental Epigenetics1
Rosenfeld, C. S. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.080952 · Cited by 112
Tesseraud, S., Métayer, S., Collin, A., & Seiliez, I. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508159025 · Cited by 136
Chen, S., Wang, Y., Zhou, W., Li, S., Peng, J., Shi, Z., Hu, J., Liu, J. Y.-C., Ding, H., Lin, Y.-J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501134e · Cited by 122
Turning tumors from cold to inflamed to improve immunotherapy response
Gerard, C. L., Delyon, J., Wicky, A. M., Homicskó, K., Cuendet, M. A., & Michielin, O. A. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102227 · Cited by 131
Sun, N., Ye, C., Zhao, Q., Zhang, Q., Xu, C., Wang, S., Jin, Z., Sun, S., Wang, F., & Li, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100340 · Cited by 115
RetractedJoven, J., Micol, V., Segura‐Carretero, A., Alonso‐Villaverde, C., Menéndez, J. A., & for the Bioactive Food Components, P. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.621772 · Cited by 139
MicroRNAs as targets for antisense-based therapeutics
Stenvang, J., & Kauppinen, S. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.1.59 · Cited by 116
Khan, F., Momtaz, S., & Abdollahi, M. R. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.11.006 · Cited by 117
Epigenomic Dysregulation in Schizophrenia: In Search of Disease Etiology and Biomarkers
Khavari, B., & Cairns, M. J. (2020) · Cells · doi:10.3390/cells9081837 · Cited by 145
Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Joshi, D. C., Sharma, A., Prasad, S., Singh, K., Kumar, M., Sherawat, K., Tuli, H. S., & Gupta, M. (2024) · Discover Oncology · doi:10.1007/s12672-024-01195-7 · Cited by 128
From UVs to Metastases: Modeling Melanoma Initiation and Progression in the Mouse
Zaidi, M. R., Day, C., & Merlino, G. T. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.177 · Cited by 149
Filkowski, J. N., Ilnytskyy, Y., Tamminga, J., Koturbash, I., Golubov, A., Bagnyukova, T., Pogribny, I. P., & Kovalchuk, O. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp300 · Cited by 111
Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
Ma, L., Chua, M.-S., Andrisani, O., & So, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.333 · Cited by 121
Regulation of Cancer Germline Antigen Gene Expression: Implications for Cancer Immunotherapy
Akers, S. N., Odunsi, K. O., & Karpf, A. R. (2010) · Future Oncology · doi:10.2217/fon.10.36 · Cited by 114
Epigenetic Modulation of Tumor Suppressor CCAAT/Enhancer Binding Protein α Activity in Lung Cancer
Tada, Y., Brena, R. M., Hackanson, B., Morrison, C., Otterson, G. A., & Plass, C. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj093 · Cited by 115
Cancer as a Manifestation of Aberrant Chromatin Structure
Brock, M. V., Herman, J. G., & Baylin, S. B. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e31803c5415 · Cited by 123
Pathogenesis, multi-omics research, and clinical treatment of psoriasis
Yu, J., Zhao, Q., Wang, X., Zhou, H., Hu, J. Y., Gu, L., Hu, Y., Zeng, F., Zhao, F., Yue, C., et al. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102916 · Cited by 124
Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition
Lakshmikuttyamma, A., Scott, S. A., DeCoteau, J. F., & Geyer, C. R. (2010) · Oncogene · doi:10.1038/onc.2009.361 · Cited by 110
Steensma, D. P., Gibbons, R. J., & Higgs, D. R. (2004) · Blood · doi:10.1182/blood-2004-07-2792 · Cited by 122
Histone Deacetylase Inhibitors: Biology and Mechanism of Action
Mehnert, J. M., & Kelly, W. K. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e31803c72ba · Cited by 124
CDKL5 is a brain MeCP2 target gene regulated by DNA methylation
Carouge, D., Host, L., Aunis, D., Zwiller, J., & Anglard, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.02.014 · Cited by 108
Mund, C., Hackanson, B. W., Stresemann, C., Lübbert, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0695 · Cited by 119
Khoshfetrat, S. M., Dorraji, P. S., Fotouhi, L., Hosseini, M., Khatami, F., Moazami, H. R., & Omidfar, K. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.131895 · Cited by 111
Zhang, Q., Hu, G., Yang, Q., Dong, R., Xie, X., Ma, D., Shen, K., & Kong, B. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.04.048 · Cited by 111
DNA and histone methylation in gastric carcinogenesis
Calcagno, D. Q., Gigek, C. O., Chen, E. S., Burbano, R. R., & Smith, M. D. A. C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1182 · Cited by 112
Genetic and epigenetic mechanisms of epilepsy: a review
Chen, T., Giri, M., Xia, Z., Subedi, Y. N., & Li, Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s142032 · Cited by 126
Qin, H., Zhu, X., Liang, J. F., Wu, J., Yang, Y., Wang, S., Shi, W., & Xu, J. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.10.011 · Cited by 113
Epigenetic Changes in the Myelodysplastic Syndrome
Issa, J.-P. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.02.007 · Cited by 106
Alcohol and NMDA receptor: current research and future direction
Chandrasekar, R. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00014 · Cited by 124
Sadakierska−Chudy, A., Kostrzewa, R. M., & Filip, M. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9497-5 · Cited by 126
Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer
Lin, R.-K., & Wang, Y. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-46 · Cited by 119
Managing the Microbial Community of Marine Fish Larvae: A Holistic Perspective for Larviculture
Vadstein, Ô., Attramadal, K. J. K., Bakke, I., Forberg, T., Ôlsen, Y., Verdegem, M. C. J., Giatsis, C., Skjermo, J., Aasen, I. M., Gatesoupe, F.-J., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01820 · Cited by 117
Dissecting miRNA signature in colorectal cancer progression and metastasis
Huang, X., Zhu, X., Yu, Y., Zhu, W., Jin, L., Zhang, X., Li, S., Zou, P., Xie, C., & Cui, R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.025 · Cited by 114
Keeping up NF-κB appearances: Epigenetic control of immunity or inflammation-triggered epigenetics
Berghe, W. V., Ndlovu, ’. N., Hoya-Arias, R., Dijsselbloem, N., Gerlo, S., & Haegeman, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.012 · Cited by 122
DNA methylation in Parkinson's disease
Wüllner, U., Kaut, O., deBoni, L., Piston, D., & Schmitt, I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13646 · Cited by 107
Histone modifications silence the GATA transcription factor genes in ovarian cancer
Caslini, C., Capo‐chichi, C. D., Roland, I., Nicolas, É., Yeung, A. T., & Xx, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209533 · Cited by 115
Epigenetic mechanisms and gastrointestinal development
Waterland, R. A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.064 · Cited by 118
Issa, J. J., Shen, L., & Toyota, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.040 · Cited by 122
DNA Methylation and Structural and Functional Bimodality of Vertebrate Promoters
Elango, N., & Yi, S. V. (2008) · Molecular Biology and Evolution · doi:10.1093/molbev/msn110 · Cited by 120
Maslak, P. G., Chanel, S. M., Camacho, L. H., Soignet, S. L., Pandolfi, P. P., Guernah, I., Warrell, R. P., & Nimer, S. D. (2005) · Leukemia · doi:10.1038/sj.leu.2404050 · Cited by 111
Li, X., Shao, Y., Sha, X., Fang, P., Kuo, Y., Andrews, A. J., Li, Y., Yang, W. Y., Maddaloni, M., Pascual, D. W., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310626 · Cited by 115
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
Trujillo, B., Wu, A., Wetterskog, D., & Attard, G. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01881-9 · Cited by 116
Oligomerization and Binding of the Dnmt3a DNA Methyltransferase to Parallel DNA Molecules
Jurkowska, R. Z., Rajavelu, A., Anspach, N., Urbanke, C., Jankevicius, G., Ragozin, S., Nellen, W., & Jeltsch, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.254987 · Cited by 100
Kiguchi, N., Kobayashi, Y., Maeda, T., Fukazawa, Y., Tohya, K., Kimura, M., & Kishioka, S. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187724 · Cited by 111
Basse, C., & Arock, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29347 · Cited by 118
Tang, J. T., Wang, J., Du, W., Hong, J., Zhao, S., Wang, Y., Xiong, H., Chen, H., & Fang, J. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr114 · Cited by 116
Epithelial Mutations in Endometriosis: Link to Ovarian Cancer
Bulun, S. E., Wan, Y., & Matei, D. (2019) · Endocrinology · doi:10.1210/en.2018-00794 · Cited by 104
Choline: Dietary Requirements and Role in Brain Development
Sanders, L. M., & Zeisel, S. H. (2007) · Nutrition Today · doi:10.1097/01.nt.0000286155.55343.fa · Cited by 105
Epigenetic combination therapy as a tumor‐selective treatment approach for hepatocellular carcinoma
Venturelli, S., Armeanu, S., Pathil, A., Hsieh, C., Weiß, T. S., Vonthein, R., Wehrmann, M., Gregor, M., Lauer, U. M., & Bitzer, M. (2007) · Cancer · doi:10.1002/cncr.22652 · Cited by 110
Overview of Cancer Epigenetics
Jones, P. A. (2005) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.05.001 · Cited by 116
Self-citationThe paternal epigenome and embryogenesis: poising mechanisms for development
Jenkins, T. G., & Carrell, D. T. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2010.61 · Cited by 103
Brena, R. M., Huang, T. H. ‐., & Plass, C. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0034-0 · Cited by 114
Epigenetic regulation in male germ cells
Zamudio, N., Chong, S., & O’Bryan, M. K. (2008) · Reproduction · doi:10.1530/rep-07-0576 · Cited by 115
MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1
Shi, L., Zhang, B., Sun, X., Lu, S., Liu, Z., Liu, Y., Li, H., Wang, L., Wang, X., & Zhao, C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.580 · Cited by 103
Visvanathan, K., Fackler, M. S., Zhang, Z., Lopez-Bujanda, Z. A., Jeter, S. C., Sokoll, L. J., Garrett-Mayer, E., Cope, L. M., Umbricht, C. B., Euhus, D. M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2015.66.2080 · Cited by 102
Pathophysiological Fundamentals of Diabetic Cardiomyopathy
Hu, X., Bai, T., Xu, Z., Liu, Q., Zheng, Y., & Cai, L. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160021 · Cited by 122
Abnormal Epigenetic Regulation of Immune System during Aging
Jasiulionis, M. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00197 · Cited by 110
Control of viral infections by epigenetic-targeted therapy
Nehme, Z., Pasquereau, S., & Herbein, G. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0654-9 · Cited by 107
Detection and manipulation of methylation in blood cancer DNA using terahertz radiation
Cheon, H., Paik, J. H., Choi, M., Yang, H.-J., & Son, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-42855-x · Cited by 112
Runx2 plays a central role in Osteoarthritis development
Chen, D., Kim, D. J., Shen, J., Zou, Z., & O’Keefe, R. J. (2019) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2019.11.008 · Cited by 116
Suzuki, T., Tanaka, R., Hamada, S., Nakagawa, H., & Miyata, N. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.016 · Cited by 103
Biological Functions of Methyl-CpG-Binding Proteins
Defossez, P., & Stancheva, I. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-387685-0.00012-3 · Cited by 119
Environment-Sensitive Epigenetics and the Heritability of Complex Diseases
Furrow, R. E., Christiansen, F. B., & Feldman, M. W. (2011) · Genetics · doi:10.1534/genetics.111.131912 · Cited by 100
Akiyama, T., Li, X., Oda, M., Sharov, A. A., Amano, M., Piao, Y., Cadet, J. S., Dudekula, D. B., Qian, Y., Wang, W., et al. (2015) · DNA Research · doi:10.1093/dnares/dsv013 · Cited by 106
Natte, K., Neumann, H., Jagadeesh, R. V., & Beller, M. (2017) · Nature Communications · doi:10.1038/s41467-017-01428-0 · Cited by 107
Kok, R. M., Smith, D. E. C., Barto, R., Spijkerman, A. M. W., Teerlink, T., Gellekink, H., Jakobs, C., & Smulders, Y. M. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.137 · Cited by 102
Tang, Y., Xiong, J., Jiang, H.-P., Zheng, S.-J., Feng, Y., & Yuan, B. (2014) · Analytical Chemistry · doi:10.1021/ac5016886 · Cited by 103
Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration
Hu, Y., Sun, X., Mao, C., Guo, G., Ye, S., Xu, J., Zou, R., Chen, J., Wang, L., Duan, P., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.994 · Cited by 103
Genome-Wide Analysis of DNA Methylation and Acute Coronary Syndrome
Li, J., Zhu, X., Yu, K., Jiang, H., Zhang, Y., Deng, S., Cheng, L., Liu, X., Zhong, J., Zhang, X., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.310324 · Cited by 109
Hassler, M. R., Bray, F., Catto, J. W. F., Grollman, A. P., Hartmann, A., Margulis, V., Matin, S. F., Morgan Rouprêt, A., Sfakianos, J. P., Shariat, S. F., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.05.039 · Cited by 103
Schagdarsurengin, U., Gimm, O., Dralle, H., Hoang‐Vu, C., & Dammann, R. (2006) · Thyroid · doi:10.1089/thy.2006.16.633 · Cited by 101
Yoo, S., Takikawa, S., Geraghty, P., Argmann, C., Campbell, J., Lin, L., Huang, T., Tu, Z., Feronjy, R., Spira, A., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004898 · Cited by 105
Vitamin C – A new player in regulation of the cancer epigenome
Gillberg, L., Ørskov, A. D., Liu, M., Harsløf, L. B. S., Jones, P. A., & Grønbæk, K. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.001 · Cited by 100
Self-citationPatani, N., Jiang, W. G., Newbold, R. F., & Mokbel, K. (2011) · PubMed · Cited by 100
Shigaki, H., Baba, Y., Watanabe, M., Murata, A., Iwagami, S., Miyake, K., Ishimoto, T., Iwatsuki, M., & Baba, H. (2012) · Gastric Cancer · doi:10.1007/s10120-012-0209-7 · Cited by 110
Polycystic ovary syndrome: Understanding the role of the brain
Moore, A. M., & Campbell, R. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.002 · Cited by 113
Fetal alcohol spectrum disorders and their transmission through genetic and epigenetic mechanisms
Mead, E. A., & Sarkar, D. K. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00154 · Cited by 109
Zhou, Q. Y., Huang, S., Zhang, F., Li, S., Liu, C., Xi, Y., Wang, L., Wang, X., He, Q., Sun, C., et al. (2017) · Cell Proliferation · doi:10.1111/cpr.12394 · Cited by 115
The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy
Loo Yau, H., Ettayebi, I., & De Carvalho, D. D. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.07.006 · Cited by 96
Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors
Han, M., Jia, L., Lv, W., Wang, L., & Cui, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00194 · Cited by 103
Li, Y., & Tollefsbol, T. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017421 · Cited by 97
Morris, K. V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5182-4 · Cited by 102
Genetic and nutrient determinants of the metabolic syndrome
Phillips, C. M., López‐Miranda, J., Pérez‐Jiménez, F., McManus, R., & Roche, H. M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221579.25878.11 · Cited by 117
Fenech, M. F. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.06.035 · Cited by 100
Junien, C., & Nathanielsz, P. W. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00371.x · Cited by 110
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.